Page last updated: 2024-11-02

oxybutynin and Melanoma

oxybutynin has been researched along with Melanoma in 2 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)

Research Excerpts

ExcerptRelevanceReference
" As a worst-case scenario for consequences of repeated application on neoplastic growth, the melanin-binding drug, rasagiline, was used in a transdermal formulation applied directly to a human-derived melanoma to determine the effects on tumor growth."7.78Comparison of oral and transdermal administration of rasagiline mesylate on human melanoma tumor growth in vivo. ( Arjmand, FM; Christianson, C; Dines, K; Hamlin, R; Huang, B; Meier-Davis, SR; Nagata, T; Shudo, J; Wen, J, 2012)
" As a worst-case scenario for consequences of repeated application on neoplastic growth, the melanin-binding drug, rasagiline, was used in a transdermal formulation applied directly to a human-derived melanoma to determine the effects on tumor growth."3.78Comparison of oral and transdermal administration of rasagiline mesylate on human melanoma tumor growth in vivo. ( Arjmand, FM; Christianson, C; Dines, K; Hamlin, R; Huang, B; Meier-Davis, SR; Nagata, T; Shudo, J; Wen, J, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Han, X1
Li, H1
Zhou, D1
Chen, Z1
Gu, Z1
Meier-Davis, SR1
Dines, K1
Arjmand, FM1
Hamlin, R1
Huang, B1
Wen, J1
Christianson, C1
Shudo, J1
Nagata, T1

Other Studies

2 other studies available for oxybutynin and Melanoma

ArticleYear
Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
    Accounts of chemical research, 2020, 11-17, Volume: 53, Issue:11

    Topics: Animals; Antibodies, Monoclonal; B7-H1 Antigen; Disease Models, Animal; Drug Delivery Systems; Extra

2020
Comparison of oral and transdermal administration of rasagiline mesylate on human melanoma tumor growth in vivo.
    Cutaneous and ocular toxicology, 2012, Volume: 31, Issue:4

    Topics: Administration, Cutaneous; Administration, Oral; Animals; Antineoplastic Agents; Disease Models, Ani

2012